New, Dangerous Synthetic Opioid in D.C., Emerging in Tri-State Area
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip
June 01, 2022

New, Dangerous Synthetic Opioid in D.C., Emerging in Tri-State Area

DEA Washington, DC Division

vials for testing
capsules that contain nitazene
scientist testing nitazene in a beaker
scientist standing in the lab testing nitazene
nitazene powder
nitazene in pill form

 

illicit pills

The DEA Washington Division is warning area residents of a new drug, emerging in the D.C. metropolitan area that is as dangerous and deadly as fentanyl.

This week, the DEA Washington Division brought local news outlets into their regional laboratory to see and discuss a dangerous class of drugs they are seeing emerge in the region -- nitazenes.  A drug that was never approved for medical use, nitazines are being sourced from China and being mixed into other drugs.

Isotonitazene (aka nitazene or "ISO”) is a particular synthetic opioid the DEA is seeing move into the area. First identified around 2019 in the Midwest, this dangerous drug has moved into the Southern states and, more recently, along the Eastern seaboard. Much more potent than heroin and morphine (similar to fentanyl), ISO is being mixed into and marketed as other drugs to make drugs more potent and cheaper to produce. The major concern: This drug can and has caused deadly overdoses in unsuspecting victims.

nitazene in powder form in large gallon baggies

In powder form, ISO can appear yellow, brown, or off-white in color. DEA regional forensic laboratories have seen this drug mixed into heroin and/or fentanyl (and marketed as common street drugs) with deadly consequences. However, in other parts of the country, ISO has already been seen pressed into counterfeit pills and falsely marketed as pharmaceutical medication (like Dilaudid "M-8" tablets and oxycodone "M30" tablets).

ISO’s high potency comes with an increased risk of overdose – a big issue the DEA Washington Division is currently working to tackle. According to provisional CDC data, in 2021, U.S. drug overdose deaths hit their highest level on record -- nearly 108,000 people. Even more concerning: over 75% of those deaths involved a synthetic opioid.

Tragically, many of these overdose victims have no idea they are ingesting these dangerous and extremely potent drugs. The DEA says these synthetic opioids currently can only be properly identified after a lab test, so people don't realize they're buying them until it's too late.

DEA Intelligence Instructor holding a bag of illicit nitazene pills

“We want to get this info out and warn people,” says Jarod Forget, Special Agent in Charge of the DEA Washington Division. “If we can educate and inform our communities about the dangers of taking counterfeit prescription pills or other drugs, we stem the proliferation of these deadly opioids, stop all of these senseless deaths, and help keep our neighbors and loved ones safe. “

Currently, nitazene reports are still relatively low, especially compared to fentanyl. However, officials say this emerging drug is something to keep an eye on.

"People have to keep in mind, with all the synthetic drugs out there, and the way they’re being mixed together, you never know what you’re actually buying," says DEA Intelligence Analyst Maura Gaffney. Only take medications prescribed by your doctor and dispensed by your licensed pharmacist because pills or drugs obtained elsewhere are unsafe and are often deadly.

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster